Matches in SemOpenAlex for { <https://semopenalex.org/work/W2548432952> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2548432952 endingPage "5062" @default.
- W2548432952 startingPage "5062" @default.
- W2548432952 abstract "Abstract Backround: The treatment of mycosis fungoides (MF) is determined by disease extent, prognostic factors and patient characteristics. Extracorporeal Photopheresis (ECP) was approved by the US Food and Drug Administiration for the palliative treatment of mycosis fungoides since 1988. Herein, we present our MF patients who have received ECP. Patients and Methods: We retrospectively included 50 MF patients who have diagnosed at our center. ECP was given empirically in cycles of 2 consecutive days in every 2 to 4 weeks at any time during their follow-up. Results: The patient characteristics is shown in table. Previous lines of treatments were; topical retinoids (bexarotene), topical corticosteroids, phototherapy (PUVA), Narrowband ultraviolet B light (NBUVB), Interferons, Metotrexate (MTX), CHOP (cyclophosphamide, daunorubicin, vincristine, prednisolone). ECP is combined with gemcitabine, PUVA, MTX, Bexaroten, IFN or Vorinostat. The overall response rate (ORR) was 54% with 30% complete response rate (CRR). 10/15 complete responders (67%) had stage 3-4 disease at diagnosis and 7/15 (47%) had received ≥ 3 lines of treatment prior to ECP. 18 patients (36%) had progressive disease after ECP while 3 patients (6%) were refractory and underwent allogeneic stem cell transplantation. The few adverse events of ECP included in 8 patients (16%) as catheter-related infection, headache, fever, chills and nausea. The OS was 68 months. Conclusion: ECP is a favorable treatment option for suitable patients in MF with high ORR and low risk of adverse events. Presenter has relevant financial relationship(s) to disclose: No. Disclosures No relevant conflicts of interest to declare." @default.
- W2548432952 created "2016-11-11" @default.
- W2548432952 creator A5002939193 @default.
- W2548432952 creator A5011716290 @default.
- W2548432952 creator A5030401832 @default.
- W2548432952 creator A5038588053 @default.
- W2548432952 creator A5043084722 @default.
- W2548432952 creator A5054407596 @default.
- W2548432952 creator A5065201669 @default.
- W2548432952 creator A5070704251 @default.
- W2548432952 creator A5076735212 @default.
- W2548432952 creator A5081218567 @default.
- W2548432952 creator A5085246270 @default.
- W2548432952 date "2015-12-03" @default.
- W2548432952 modified "2023-09-27" @default.
- W2548432952 title "Extracorporeal Photopheresis for the Treatment of Mycosis Fungoides" @default.
- W2548432952 doi "https://doi.org/10.1182/blood.v126.23.5062.5062" @default.
- W2548432952 hasPublicationYear "2015" @default.
- W2548432952 type Work @default.
- W2548432952 sameAs 2548432952 @default.
- W2548432952 citedByCount "1" @default.
- W2548432952 countsByYear W25484329522020 @default.
- W2548432952 crossrefType "journal-article" @default.
- W2548432952 hasAuthorship W2548432952A5002939193 @default.
- W2548432952 hasAuthorship W2548432952A5011716290 @default.
- W2548432952 hasAuthorship W2548432952A5030401832 @default.
- W2548432952 hasAuthorship W2548432952A5038588053 @default.
- W2548432952 hasAuthorship W2548432952A5043084722 @default.
- W2548432952 hasAuthorship W2548432952A5054407596 @default.
- W2548432952 hasAuthorship W2548432952A5065201669 @default.
- W2548432952 hasAuthorship W2548432952A5070704251 @default.
- W2548432952 hasAuthorship W2548432952A5076735212 @default.
- W2548432952 hasAuthorship W2548432952A5081218567 @default.
- W2548432952 hasAuthorship W2548432952A5085246270 @default.
- W2548432952 hasConcept C126322002 @default.
- W2548432952 hasConcept C141071460 @default.
- W2548432952 hasConcept C16005928 @default.
- W2548432952 hasConcept C197934379 @default.
- W2548432952 hasConcept C2776780870 @default.
- W2548432952 hasConcept C2777756187 @default.
- W2548432952 hasConcept C2779338263 @default.
- W2548432952 hasConcept C2779972918 @default.
- W2548432952 hasConcept C2780580376 @default.
- W2548432952 hasConcept C2781468836 @default.
- W2548432952 hasConcept C2909962264 @default.
- W2548432952 hasConcept C2911091166 @default.
- W2548432952 hasConcept C71924100 @default.
- W2548432952 hasConcept C90924648 @default.
- W2548432952 hasConceptScore W2548432952C126322002 @default.
- W2548432952 hasConceptScore W2548432952C141071460 @default.
- W2548432952 hasConceptScore W2548432952C16005928 @default.
- W2548432952 hasConceptScore W2548432952C197934379 @default.
- W2548432952 hasConceptScore W2548432952C2776780870 @default.
- W2548432952 hasConceptScore W2548432952C2777756187 @default.
- W2548432952 hasConceptScore W2548432952C2779338263 @default.
- W2548432952 hasConceptScore W2548432952C2779972918 @default.
- W2548432952 hasConceptScore W2548432952C2780580376 @default.
- W2548432952 hasConceptScore W2548432952C2781468836 @default.
- W2548432952 hasConceptScore W2548432952C2909962264 @default.
- W2548432952 hasConceptScore W2548432952C2911091166 @default.
- W2548432952 hasConceptScore W2548432952C71924100 @default.
- W2548432952 hasConceptScore W2548432952C90924648 @default.
- W2548432952 hasIssue "23" @default.
- W2548432952 hasLocation W25484329521 @default.
- W2548432952 hasOpenAccess W2548432952 @default.
- W2548432952 hasPrimaryLocation W25484329521 @default.
- W2548432952 hasRelatedWork W135072596 @default.
- W2548432952 hasRelatedWork W1813742668 @default.
- W2548432952 hasRelatedWork W1980366424 @default.
- W2548432952 hasRelatedWork W2318889189 @default.
- W2548432952 hasRelatedWork W2327768469 @default.
- W2548432952 hasRelatedWork W2366180244 @default.
- W2548432952 hasRelatedWork W2487488967 @default.
- W2548432952 hasRelatedWork W2603073056 @default.
- W2548432952 hasRelatedWork W2986997815 @default.
- W2548432952 hasRelatedWork W3165759803 @default.
- W2548432952 hasVolume "126" @default.
- W2548432952 isParatext "false" @default.
- W2548432952 isRetracted "false" @default.
- W2548432952 magId "2548432952" @default.
- W2548432952 workType "article" @default.